Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against...
Enregistré dans:
Auteurs principaux: | Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec Pankow, Natalie L. Smith, Xaquin Castro Dopico, Gerald M. McInerney, Jonathan M. Coquet, Gunilla B. Karlsson Hedestam, Ben Murrell |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
par: Leo Hanke, et autres
Publié: (2020) -
Investigating the Concerns of First-Time Distance Education Instructors
par: Halil Kayaduman, et autres
Publié: (2019) -
Model-Based Prediction of an Effective Adhesion Parameter Guiding Multi-Type Cell Segregation
par: Philipp Rossbach, et autres
Publié: (2021) -
Examining the Relative Influence of Risk and Control on Intention to Adopt Risky Technologies
par: Gupta,Sumeet, et autres
Publié: (2010) -
Mapping Population Distribution Based on XGBoost Using Multisource Data
par: Xin Zhao, et autres
Publié: (2021)